• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  01/28/2011
Trade Name:  MENVEO
Generic or Proper Name (*):  Meningococcal (Groups A, C, Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine*
Indications Studied:  Active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135
Therapeutic Category:  Preventive Vaccine
Ages Studied:  2 - <11 years
Study #:  1
Study Type:  Safety/Immunogenicity
Study Design:  Open Label
No Patients:  2907
No Centers:  62
No Countries:  2